O Brien Greene & Co. Inc Buys Shares of 4,222 M.D.C. Holdings, Inc. (NYSE:MDC)

O Brien Greene & Co. Inc bought a new stake in M.D.C. Holdings, Inc. (NYSE:MDC) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,222 shares of the construction company’s stock, valued at approximately $233,000.

Several other large investors also recently bought and sold shares of the company. Ronald Blue Trust Inc. grew its holdings in M.D.C. by 100.0% in the third quarter. Ronald Blue Trust Inc. now owns 640 shares of the construction company’s stock valued at $26,000 after purchasing an additional 320 shares during the last quarter. Nilsine Partners LLC lifted its position in shares of M.D.C. by 6.9% in the fourth quarter. Nilsine Partners LLC now owns 5,353 shares of the construction company’s stock valued at $296,000 after acquiring an additional 344 shares in the last quarter. CWM LLC lifted its position in shares of M.D.C. by 31.7% in the third quarter. CWM LLC now owns 1,447 shares of the construction company’s stock valued at $60,000 after acquiring an additional 348 shares in the last quarter. Meritage Portfolio Management lifted its position in shares of M.D.C. by 5.6% in the fourth quarter. Meritage Portfolio Management now owns 6,998 shares of the construction company’s stock valued at $387,000 after acquiring an additional 373 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of M.D.C. by 20.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,331 shares of the construction company’s stock valued at $96,000 after acquiring an additional 395 shares in the last quarter. Institutional investors and hedge funds own 88.08% of the company’s stock.

M.D.C. Stock Performance

M.D.C. stock opened at $62.98 on Friday. The stock’s 50-day moving average is $62.79 and its 200-day moving average is $54.63. The company has a market cap of $4.73 billion, a price-to-earnings ratio of 11.93 and a beta of 1.54. The company has a debt-to-equity ratio of 0.50, a current ratio of 9.76 and a quick ratio of 3.92. M.D.C. Holdings, Inc. has a 12 month low of $36.47 and a 12 month high of $63.00.

M.D.C. (NYSE:MDC) last released its quarterly earnings data on Tuesday, January 30th. The construction company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.50 by $0.06. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.29 billion. M.D.C. had a return on equity of 12.32% and a net margin of 8.64%. The company’s quarterly revenue was down 11.9% compared to the same quarter last year. During the same period last year, the business posted $1.08 EPS. Equities analysts anticipate that M.D.C. Holdings, Inc. will post 5.7 earnings per share for the current year.

Insider Transactions at M.D.C.

In other news, Director David E. Blackford sold 6,200 shares of the firm’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $62.69, for a total value of $388,678.00. Following the transaction, the director now directly owns 13,534 shares in the company, valued at approximately $848,446.46. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 23.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Evercore ISI downgraded M.D.C. from an “outperform” rating to an “in-line” rating and upped their price objective for the company from $57.00 to $63.00 in a research report on Wednesday, January 31st. StockNews.com started coverage on M.D.C. in a research report on Saturday. They set a “hold” rating on the stock. Finally, Raymond James reiterated a “market perform” rating on shares of M.D.C. in a research report on Wednesday, February 7th. One research analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $52.13.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.